Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
IM Cannabis Corp ( (IMCC) ) has issued an update.
On April 6, 2026, IM Cannabis Corp. entered into a note purchase agreement with an institutional investor to issue a US$250,000 convertible note and a warrant for up to 272,861 common shares. The net proceeds of approximately US$225,000 are earmarked for general corporate purposes, with the offering expected to close on April 7, 2026.
The note carries 8% annual interest, rising to 14% on default, and is repayable only in shares at a conversion price tied to the lower of a fixed US$0.339 level or a market-based formula with a US$0.07 floor. The accompanying five-year warrant is immediately exercisable at CAD$0.47, while IM Cannabis has committed to reserve sufficient shares and file a resale registration to facilitate potential share issuance and liquidity for the investor, underscoring its reliance on equity-linked financing amid listing and regulatory pressures.
The most recent analyst rating on (IMCC) stock is a Hold with a $0.30 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Underperform.
The score is held down primarily by stressed fundamentals (negative equity and ongoing losses) despite improved 2025 cash flow, and by very bearish technical signals with the stock trading far below key moving averages. Valuation provides limited support because the company is currently loss-making and no dividend yield is available.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is an Israel-based medical cannabis company listed on the Nasdaq Capital Market. It focuses on supplying medical cannabis products, with key operations and regulatory exposure in Israel and Germany, two tightly regulated markets that are central to its growth plans and licensing strategy.
Average Trading Volume: 282,186
Technical Sentiment Signal: Sell
Current Market Cap: $2.11M
For a thorough assessment of IMCC stock, go to TipRanks’ Stock Analysis page.